Генетический анализ вируса гриппа А / Н1N1 "пандемический" в условиях эпидемии

Генетический анализ вируса гриппа А / Н1N1 "пандемический" в условиях эпидемии.

1. "Transcript of virtual press conference with Dr Keiji Fukuda, Assistant Director-General ad Interim for Health Security and Environment, World Health Organization". World Health Organization. 2009-07-07. http://www.who.int/mediacentre/Pandemic_h1n1_presstranscript_2009_07_07.pdf.

2. "Interim Novel Influenza A (H1N1) Guidance for Cruise Ships". Centers for Disease Control and Prevention. 2009-08-05. http://www.cdc.gov/h1n1flu/guidance/cruiseships. html.

3. Chan M. World now at the start of 2009 influenza pandemic. World Health Organization. 2009-06-11. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_ 20090611/en/index.html.

4. "CDC Briefing on Investigation of Human Cases of H1N1 Flu". Centers for Disease Control and Prevention. 2009-07-24. http://www.webcitation.org/5jeG7e0IC

5. Interim Guidance for 2009 H1N1 Flu (Swine Flu): Taking Care of a Sick Person in Your Home. Centers for Disease Control and Prevention. 2009-08-05. http://www.cdc.gov/h1n1flu/guidance_homecare.html.

6. Mauad T., Hajjar L.A., Callegari G.D. et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 2010; 181 (1): 72–79.

7. Clinical features of severe cases of pandemic influenza. World Health Organization. 2009-10-16 http://www.who. int/csr/disease/swineflu/notes/h1n1_clinical_features_20091016/en

8. CDC protocol of realtime RTPCR for influenza A (H1N1). World Health Organization. http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay)2009_20090430.pdf.

9. Ilina E.N., Malakhova M.V., Generozov E.V. et al. Matrixassisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping. J. Clin. Microbiol. 2005; 43 (6): 2810–2815.

10. Sequencing primers and protocol. World Health Organization. http://www.who.int/csr/resources/publications/swineflu/GenomePrimers_20090512.pdf.

11. Le Q.M., Wertheim H.F., Tran N.D. et al. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 2010; 362 (1): 86–87.

12. Gulland A. First cases of spread of oseltamivir resistant swine flu between patients are reported in Wales. Br. Med. J. 2009; 339: b4975.

13. Eshaghi A., Bolotin S., Burton L. et al. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007–2008 respiratory seasons. J. Clin. Virol. 2009; 45: 142–145.

14. Holsinger L.J., Nichani D., Pinto L.H. et al. Influenza A virus M2 ion channel protein: a structure-function analysis. J. Virol. 1994; 68 (3): 1551–1563.

15. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell 1992; 69 (3): 517-528.

16. Pinto L.H., Lamb R.A. Controlling influenza virus replication by inhibiting its proton channel. Mol. Biosyst. 2007; 3 (1): 18–23.

17. Wang W.Y.S., Glenn C.L., Zhang W. et al. Exclusion of angiotensinogen gene in molecular basis of human hypertension: sibpair linkage and association analyses in Australian Anglo-Caucasians. Am. J. Med. Genet. 1999; 87: 53–60.

18. Kobashi G., Yamada H., Ohta K. et al. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am. J. Med. Genet. 2001; 103: 241–244.

19. Contopoulos-Ioannidis D.G., Manoli E.N., Ioannidis J.P.A. Meta-analysis of the association of beta-2-adrenergic receptor polymorphisms with asthma phenotypes. J. Allergy Clin. Immunol. 2005; 115: 963–972.

20. Lahti M., Marttila R., Hallman M. Surfactant protein C gene variation in the Finnish population-association with perinatal respiratory disease. Eur. J. Hum. Genet. 2004; 12: 312–320.

21. Nogee L.M., Dunbar A.E., Wert S. et al. Mutations in the surfactant protein C gene associated with interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.

22. Joos L., He J.-Q., Shepherdson M.B. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet. 2002; 11: 569–576.

23. Franco R.F., Trip M.D., ten Cate H. et al. The 20210G-A mutation in the 3-prime-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br. J. Haematol. 1999; 104: 50–54.

24. Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E. et al. A common mutation (G(-455)-to-A) in the beta-fib-rinogen promoter is an independent predictor of plasma fib-rinogen, but not of ischemic heart disease: a study of 9,127 individuals based on the Copenhagen City Heart Study. J. Clin. Invest. 1997; 99: 3034–3039.

25. Gómez-Gómez A., Magan~a-Aquino M., García-Sepúlveda C.A. Severe pneumonia associated with Pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico. Emerg. Infect. Dis. 2010; 16: 27–34.